<?xml version="1.0" encoding="UTF-8"?>
<p>In recent studies, ar-turmerone enhanced the immune system by elevating the number of monocytes in peripheral blood [
 <xref rid="B86" ref-type="bibr">86</xref>] and exhibited antiangiogenic effects on HMEC-1 cells, zebrafish, and matrigel plug mice [
 <xref rid="B87" ref-type="bibr">87</xref>]. Hence, further in-depth and extensive studies need to be performed to demonstrate its potential as an antitumor drug against hepatobiliary cancer.
</p>
